STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes.

STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes. Virology. 2020 Jan 15;540:160-164 Authors: Koganti S, Burgula S, Bhaduri-McIntosh S Abstract The cancer-causing Epstein-Barr virus (EBV) activates the transcription factor STAT3 upon infecting B-lymphocytes. STAT3 then activates caspase 7 to degrade cellular claspin, resulting in impaired Chk1 phosphorylation. This blockade of ATR-Chk1 signaling allows EBV-transformed cells to proliferate despite DNA lesions from virus-induced replication stress. In addressing the mechanism of caspase 7 activation, we now report that in newly-infected B-cells, STAT3 transcriptionally activates the initiator caspase, caspase 9. Caspase 9 then activates caspase 7 to impair phosphorylation of Chk1 at S345. Importantly, although cleaved products of caspase 9 are detectable in infected cells, there is simultaneous increase in the alternatively-spliced dominant-negative form of caspase 9 - and - expression of dominant-negative caspase 9 is abrogated when STAT3 activation is impaired. Thus EBV, via STAT3, activates caspase 9 but also shifts the balance of transcripts towards its dominant-negative form to allow activation of caspase 7 while avoiding death of EBV-infected cells. PMID: 31928997 [PubMed - in process]
Source: Virology - Category: Virology Authors: Tags: Virology Source Type: research